CHEBI:17226 - rosmarinic acid

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name rosmarinic acid
Definition The 1-carboxy-2-(2,4-dihydroxyphenyl)ethyl ester of trans-caffeic acid.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:8895, CHEBI:8894, CHEBI:15055, CHEBI:26582
Supplier Information
Download Molfile XML SDF
more structures >>
Formula C18H16O8
Net Charge 0
Average Mass 360.31480
Monoisotopic Mass 360.08452
InChI InChI=1S/C18H16O8/c19-12-4-1-10(7-14(12)21)3-6-17(23)26-16(18(24)25)9-11-2-5-13(20)15(22)8-11/h1-8,16,19-22H,9H2,(H,24,25)/b6-3+
SMILES OC(=O)C(Cc1ccc(O)c(O)c1)OC(=O)\C=C\c1ccc(O)c(O)c1
Roles Classification
Chemical Role(s): antioxidant
A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
Biological Role(s): serine proteinase inhibitor
An exogenous or endogenous compound which inhibits serine endopeptidases.
EC (aldehyde reductase) inhibitor
An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD+ or NADP+ acceptor) inhibitor that interferes with the action of aldehyde reductase (EC
plant metabolite
Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
Application(s): non-steroidal anti-inflammatory drug
An anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins.
peripheral nervous system drug
A drug that acts principally at one or more sites within the peripheral neuroeffector systems, the autonomic system, and motor nerve-skeletal system.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing rosmarinic acid (CHEBI:17226) has functional parent trans-caffeic acid (CHEBI:16433)
rosmarinic acid (CHEBI:17226) has role antioxidant (CHEBI:22586)
rosmarinic acid (CHEBI:17226) has role EC (aldehyde reductase) inhibitor (CHEBI:48550)
rosmarinic acid (CHEBI:17226) has role non-steroidal anti-inflammatory drug (CHEBI:35475)
rosmarinic acid (CHEBI:17226) has role peripheral nervous system drug (CHEBI:49110)
rosmarinic acid (CHEBI:17226) has role plant metabolite (CHEBI:76924)
rosmarinic acid (CHEBI:17226) has role serine proteinase inhibitor (CHEBI:48353)
rosmarinic acid (CHEBI:17226) is a carboxylic ester (CHEBI:33308)
rosmarinic acid (CHEBI:17226) is a monocarboxylic acid (CHEBI:25384)
rosmarinic acid (CHEBI:17226) is a phenylpropanoid (CHEBI:26004)
rosmarinic acid (CHEBI:17226) is a polyphenol (CHEBI:26195)
rosmarinic acid (CHEBI:17226) is conjugate acid of rosmarinate (CHEBI:58062)
Incoming (R)-rosmarinic acid (CHEBI:50371) is a rosmarinic acid (CHEBI:17226)
(S)-rosmarinic acid (CHEBI:50372) is a rosmarinic acid (CHEBI:17226)
rosmarinate (CHEBI:58062) is conjugate base of rosmarinic acid (CHEBI:17226)
3-(3,4-dihydroxyphenyl)-2-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]propanoic acid
Synonyms Sources
alpha-(((3,4-Dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxy- benzenepropanoic acid ChemIDplus
R-(+)-2-(3,4-Dihydroxycinnamoyloxy)-3-(3,4-dihydroxyphenyl)propionic acid ChemIDplus
Registry Number Type Source
537-15-5 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
12482446 PubMed citation Europe PMC
20071057 PubMed citation Europe PMC
21364781 PubMed citation Europe PMC
21838541 PubMed citation Europe PMC
22236574 PubMed citation Europe PMC
22439433 PubMed citation Europe PMC
23016274 PubMed citation Europe PMC
23116643 PubMed citation Europe PMC
23122135 PubMed citation Europe PMC
23381830 PubMed citation Europe PMC
23414442 PubMed citation Europe PMC
23548128 PubMed citation Europe PMC
24085626 PubMed citation Europe PMC
24097334 PubMed citation Europe PMC
24262570 PubMed citation Europe PMC
Last Modified
08 January 2016